维他奶国际(00345) - 2026 H1 - 电话会议演示
2025-11-25 08:00

Financial Performance - Vitasoy's revenue decreased by 6% from HKD 3,443 million to HKD 3,227 million [7] - Gross profit decreased by 7% from HKD 1,777 million to HKD 1,648 million [7] - Profit from operations decreased by 4% from HKD 257 million to HKD 247 million [7] - EBITDA decreased by 4% from HKD 496 million to HKD 479 million [7] - Profit to shareholders increased by 1% from HKD 171 million to HKD 172 million [7] - Basic earnings per share increased by 2% from HKD 15.9 cents to HKD 16.2 cents [9] Capital Expenditure and Cash Position - Capital expenditure increased from HKD 45 million to HKD 57 million [11] - The company's net cash position slightly increased from HKD 1,268 million to HKD 1,274 million [13] Key Ratios - Gearing remained stable at 20% [15] - ROCE remained stable at 14% [15] - Dividend per share remained at HK4.0 cents [15] Business Performance by Geography - China's total revenue decreased by 7% to HKD 2,890 million [24, 28] and operating profit decreased by 14% to HKD 326 million [26, 28] - Chinese Mainland revenue decreased by 9% to HKD 1,778 million [24, 30, 32] and operating profit decreased by 12% to HKD 191 million [26, 30, 32] - Hong Kong Operation revenue decreased by 4% to HKD 1,112 million [24, 31, 38] and operating profit decreased by 15% to HKD 135 million [26, 31, 38] - Australia & NZ revenue increased by 2% to HKD 279 million [24, 43], but experienced an operating loss of HKD 22 million [26, 43] - Singapore revenue increased by 2% to HKD 57 million [24, 48], but experienced an operating loss of HKD 1 million [26, 48]